vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Oportun Financial Corp (OPRT). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $247.7M, roughly 2.0× Oportun Financial Corp). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 1.4%, a 5.4% gap on every dollar of revenue. On growth, Oportun Financial Corp posted the faster year-over-year revenue change (-1.3% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -0.5%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Oportun Financial Corp is a US-based fintech firm that provides accessible, responsible financial services including personal loans, credit cards, and savings products to underserved low-to-moderate income consumers, many with limited or no credit history, leveraging proprietary AI underwriting to deliver fair terms while mitigating operational risk.
MD vs OPRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $247.7M |
| Net Profit | $33.7M | $3.4M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 2.6% |
| Net Margin | 6.8% | 1.4% |
| Revenue YoY | -1.7% | -1.3% |
| Net Profit YoY | 10.5% | -61.0% |
| EPS (diluted) | $0.40 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $247.7M | ||
| Q3 25 | $492.9M | $238.7M | ||
| Q2 25 | $468.8M | $234.3M | ||
| Q1 25 | $458.4M | $235.9M | ||
| Q4 24 | $502.4M | $250.9M | ||
| Q3 24 | $511.2M | $250.0M | ||
| Q2 24 | $504.3M | $250.4M | ||
| Q1 24 | $495.1M | $250.5M |
| Q4 25 | $33.7M | $3.4M | ||
| Q3 25 | $71.7M | $5.2M | ||
| Q2 25 | $39.3M | $6.9M | ||
| Q1 25 | $20.7M | $9.8M | ||
| Q4 24 | $30.5M | $8.7M | ||
| Q3 24 | $19.4M | $-30.0M | ||
| Q2 24 | $-153.0M | $-31.0M | ||
| Q1 24 | $4.0M | $-26.4M |
| Q4 25 | 9.9% | 2.6% | ||
| Q3 25 | 13.8% | 6.0% | ||
| Q2 25 | 12.8% | 4.3% | ||
| Q1 25 | 7.0% | 5.6% | ||
| Q4 24 | 7.8% | 89.6% | ||
| Q3 24 | 6.6% | -15.8% | ||
| Q2 24 | -31.3% | -19.6% | ||
| Q1 24 | 3.2% | -12.2% |
| Q4 25 | 6.8% | 1.4% | ||
| Q3 25 | 14.5% | 2.2% | ||
| Q2 25 | 8.4% | 2.9% | ||
| Q1 25 | 4.5% | 4.1% | ||
| Q4 24 | 6.1% | 200.1% | ||
| Q3 24 | 3.8% | -12.0% | ||
| Q2 24 | -30.3% | -12.4% | ||
| Q1 24 | 0.8% | -10.6% |
| Q4 25 | $0.40 | $0.07 | ||
| Q3 25 | $0.84 | $0.11 | ||
| Q2 25 | $0.46 | $0.14 | ||
| Q1 25 | $0.24 | $0.21 | ||
| Q4 24 | $0.37 | $0.26 | ||
| Q3 24 | $0.23 | $-0.75 | ||
| Q2 24 | $-1.84 | $-0.78 | ||
| Q1 24 | $0.05 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $105.5M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $390.1M |
| Total Assets | $2.2B | $3.3B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $105.5M | ||
| Q3 25 | $340.1M | $104.6M | ||
| Q2 25 | $224.7M | $96.8M | ||
| Q1 25 | $99.0M | $78.5M | ||
| Q4 24 | $229.9M | $60.0M | ||
| Q3 24 | $103.8M | $71.8M | ||
| Q2 24 | $19.4M | $72.9M | ||
| Q1 24 | $8.0M | $69.2M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $390.1M | ||
| Q3 25 | $890.7M | $383.9M | ||
| Q2 25 | $833.8M | $376.0M | ||
| Q1 25 | $789.2M | $366.1M | ||
| Q4 24 | $764.9M | $353.8M | ||
| Q3 24 | $732.5M | $327.6M | ||
| Q2 24 | $706.5M | $354.1M | ||
| Q1 24 | $856.2M | $382.0M |
| Q4 25 | $2.2B | $3.3B | ||
| Q3 25 | $2.2B | $3.2B | ||
| Q2 25 | $2.1B | $3.2B | ||
| Q1 25 | $2.0B | $3.2B | ||
| Q4 24 | $2.2B | $3.2B | ||
| Q3 24 | $2.1B | $3.3B | ||
| Q2 24 | $2.0B | $3.3B | ||
| Q1 24 | $2.2B | $3.3B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $413.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | 121.45× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $413.4M | ||
| Q3 25 | $137.3M | $99.0M | ||
| Q2 25 | $137.2M | $104.5M | ||
| Q1 25 | $-117.5M | $101.0M | ||
| Q4 24 | $133.0M | $393.5M | ||
| Q3 24 | $91.8M | $108.5M | ||
| Q2 24 | $107.0M | $107.7M | ||
| Q1 24 | $-125.2M | $85.9M |
| Q4 25 | 3.39× | 121.45× | ||
| Q3 25 | 1.91× | 19.05× | ||
| Q2 25 | 3.49× | 15.20× | ||
| Q1 25 | -5.66× | 10.34× | ||
| Q4 24 | 4.36× | 45.04× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
OPRT
Segment breakdown not available.
